We honor 100 of the leading innovators in pathology and laboratory medicine by celebrating their success at the cutting edge of the field.
As non-tuberculous mycobacterial lung disease increases, so do the efforts to find better diagnostics and treatments
It’s tricky to distinguish between valid and false-positive miRNA biomarkers – but evolutionarily conserved genetic signatures in animals could help
The combination of genome-scale CRISPR experiments and powerful computational approaches has created a Cancer Dependency Map
Higher tumor mutational burden is linked to improved survival across multiple cancer types.
Combining metabolomics and DNA sequencing could be the key to discovering new inborn errors of metabolism in children.
Genomic research has a diversity problem that could restrict the future effectiveness of precision medicine for minority groups
New guidelines for CYPC29 genotyping ensure that the correct alleles are tested and patients are prescribed the correct doses of common drugs
We speak to bioengineer Stephen Quake to learn about the noninvasive prenatal tests that have saved thousands of pregnant women’s lives
David R. Hout
Triple-negative breast cancer is not a single entity, and understanding each patient’s molecular subtype can influence treatment and outcomes
by Thermo Fisher Scientific
The move to in-house next-generation sequencing has resulted in time and tissue savings, and improved collaboration across cancer care specialties
Send me the latest from The Pathologist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.